A Study of HS-196, an HSP90 Inhibitor-linked NIR Probe for Solid Malignancies
Clinical trial NCT03333031 · TERMINATED
Trial details
- NCT number
- NCT03333031
- Sponsor
- Herbert Lyerly
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-10
- Primary completion
- 2020-10-15
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.